2D1-Fc

2D1-Fc appears to be a code name, likely designating a biologic molecule, specifically an antibody or an antibody-derived fusion protein. The "Fc" suffix strongly suggests it is an engineered protein containing an immunoglobulin Fc domain, which is commonly used to extend half-life or enhance effector function in therapeutic proteins. The "2D1" prefix typically indicates a particular clone or antibody lineage. No specific mechanism, developer, or indication has been identified in provided literature or publicly indexed sources as of the current date. No regulatory, clinical development, or marketed information is found for 2D1-Fc, and it does not appear in any pharmaceutical or clinical trial registries up to September 2025.

Other names

2D1-Fc